CVS vs FOLD · P/E 16, rev $402.07B vs rev $528.3M
CVS Health Corp (CVS) versus Amicus Therapeutics Inc (FOLD) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. FOLD currently screens at market cap $1.80B.
Not investment advice. Open the CVS and FOLD stock pages for the full models.
Not investment advice.